Finance

Lists
000963:SHE
Huadong Medicine Co., Ltd.
26,25 CN¥
-0,19%
(-0,050) 1D
16-окт., 15:04:24 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000963...
Open
26,43 CN¥
High
26,90 CN¥
Low
25,98 CN¥
Mkt. cap
46,04 млд
Avg. vol.
13,27 млн
Volume
15,87 млн
Dividend
3,54%
Quarterly dividend
0,23 CN¥
Ex-dividend date
2026-ж., 18-сен.
P/E ratio
13,27
52-wk high
43,78 CN¥
52-wk low
25,63 CN¥
EPS
1,98 CN¥
Shares outstanding
1,75 млд
No. of employees
19 миң
Open
26,43 CN¥
High
26,90 CN¥
Low
25,98 CN¥
Mkt. cap
46,04 млд
Avg. vol.
13,27 млн
Volume
15,87 млн
Dividend
3,54%
Quarterly dividend
0,23 CN¥
Ex-dividend date
2026-ж., 18-сен.
P/E ratio
13,27
52-wk high
43,78 CN¥
52-wk low
25,63 CN¥
EPS
1,98 CN¥
Shares outstanding
1,75 млд
No. of employees
19 миң
News stories
From web sources and news partners
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees19,1 миң
Founded1993-ж., 31-мар.
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
10,99 млд
10,95 млд
11,18 млд
10,88 млд
Cost of goods sold
7,39 млд
7,79 млд
7,39 млд
7,45 млд
Cost of revenue
7,39 млд
7,79 млд
7,39 млд
7,45 млд
Research and development expenses
507,92 млн
245,56 млн
350,37 млн
396,72 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,93 млд
1,99 млд
2,19 млд
1,92 млд
Operating expense
2,33 млд
2,51 млд
2,60 млд
2,41 млд
Total operating expenses
9,72 млд
10,31 млд
9,99 млд
9,86 млд
Operating income
1,27 млд
642,86 млн
1,19 млд
1,03 млд
Other non operating income
-72,11 млн
53,61 млн
-4,09 млн
-10,61 млн
EBT including unusual items
1,07 млд
753,84 млн
1,19 млд
1,02 млд
EBT excluding unusual items
1,19 млд
723,38 млн
1,19 млд
1,01 млд
Income tax expense
130,93 млн
84,85 млн
195,03 млн
176,07 млн
Effective tax rate
12,24%
11,26%
16,36%
17,28%
Other operating expenses
-105,72 млн
224,00 млн
58,88 млн
63,39 млн
Net income
933,09 млн
666,42 млн
1,00 млд
858,57 млн
Net profit margin
8,49%
6,09%
8,96%
7,89%
Earnings per share
0,54
-
-
-
Interest and investment income
26,71 млн
12,97 млн
20,16 млн
18,36 млн
Interest expense
-33,70 млн
-
-19,18 млн
-12,03 млн
Net interest expenses
-6,99 млн
12,97 млн
979,40 миң
6,33 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,46 млд
873,59 млн
1,43 млд
1,29 млд
Gain or loss from assets sale
-6,20 млн
-2,26 млн
-
-1,42 млн
AI content may include mistakes. Learn more
Google колдонмолору